RecruitingPhase 1NCT07476144

Nordic Spirit Pouch Nicotine Pharmacokinetics Abuse Liability

Nicotine Pharmacokinetics and Subjective Effects of 9 Nordic Spirit Nicotine Pouch Products in Adult Cigarette Smokers: A Controlled, Randomized, Cross-over Study With a Balanced Incomplete Block Design.


Sponsor

JT International SA

Enrollment

55 participants

Start Date

Jan 8, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Nicotine pharmacokinetics and subjective effects of 9 Nordic Spirit Nicotine Pouch Products in adult cigarette smokers: A controlled, randomized, cross-over study with a balanced incomplete block design.


Eligibility

Min Age: 22 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Participants will place the pouch between their top lip and their gum for 30 minutes as per use instructions. for people with smoking behaviors. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 22 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGParticipants will place the pouch between their top lip and their gum for 30 minutes as per use instructions.

Participants will place the pouch between their top lip and their gum for 30 minutes as per use instructions. The pouch is not to be swallowed, chewed or broken. At the end of the 30-minute period, participants will remove the pouch and the study staff will collect and dispose of it accordingly. Nicotine pouches deliver nicotine through the mucous membranes of the mouth.


Locations(2)

AMR

Knoxville, Tennessee, United States

ICON San Antonio

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07476144


Related Trials